Abstract: Disclosed is the invention to conduct immuno-adsorption of free 25(OH) vitamin D from blood or blood components, notably serum or plasma, after which the absorbed material is measured. A fluoro-alkyl surfactant is used to enhance the solubility of Vitamin D and allow the measurement of free Vitamin D. The invention thus employs a binding protein to absorb the free 25(OH) vitamin D. Thereafter the binding protein comprising the 25-OH vitamin D is subjected to a competitive binding assay with a labeled vitamin D compound, preferably radiolabeled, fluorescent labeled, luminescent labeled, biotin labeled, gold labeled or enzyme labeled. Alternatively the immunocaptured 25-OH vitamin D can be quantitated by mass spectrometry.
Type:
Grant
Filed:
April 1, 2011
Date of Patent:
February 20, 2018
Assignee:
Future Diagnostics, B.V.
Inventors:
Michaƫl Franciscus Wilhelmus Cornelis Martens, George Henry Parsons, Franciscus Maria Anna Rosmalen, Leon Maria Jacobus Wilhelmus Swinkels
Abstract: The present invention relates to a real-time test system for use in methods to analyse samples on insulin. Particularly, the invention makes it possible to carry out the analysis close to a site wherein the test results are needed. The present invention is especially suitable in intra-operative applications. The invention can be used for in and ex vivo applications.
Type:
Application
Filed:
June 25, 2004
Publication date:
November 25, 2004
Applicant:
Future Diagnostics B.V.
Inventors:
Michael Franciscus W. C. Martens, Franciscus Maria A. Rosmalen